Kleiner Perkins led a $141m Series B round in Hippocratic AI.

Kleiner Perkins, a US-based venture capital firm, led a $141m Series B round in Hippocratic AI, a US healthcare technology company, with participation from Andreessen Horowitz, General Catalyst, Premji Invest, NVIDIA, SV Angel, Universal Health Services, and WellSpan Health. "The last nine months have been a very productive period at the company. We raised our Series A with the support of Premji and NVIDIA; released our Polaris 2.0 architecture; expanded our nurse, physician, and industry advisory councils; received our first US patent; achieved safety parity of our AI agents with human clinicians; signed contracts with 23 health systems, payors, and pharma clients in just 23 weeks; launched 16 of those clients; and received a positive reception from patients. This round of financing will accelerate the development and deployment of the Hippocratic GenAI-driven super staffing and continue our quest to make healthcare abundance a reality," Munjal Shah, Hippocratic AI Co-Founder and CEO.